Two members of Dr. Dan Harki's research group were awarded fellowships for Summer 2013.
Undergraduate Jacob Edwards received a Department of Chemistry Heisig/Gleysteen Summer Undergraduate Research Fellowship.
Pharm.D. II student Bo Hu received a College of Pharmacy Melendy/Peter's Summer Research Scholarship.
ITDD Director Gunda Georg's work with Dr. Jim Maher at the Mayo Clinic is the subject of a Kare11 story published February 25, "Research Partnership Uncovers Cancer Clues."
The Star Tribune featured the story "Long-promised Pill for men gets new approach" on the front page of its Sunday, March 3 Variety section. The story includes information and quotes from Dr. Georg, Department Head of Medicinal Chemistry, about her current research targeting sperm motility.
Professor Gunda Georg, Department Head of Medicinal Chemistry and Director of the Institute for Therapeutics Discovery & Development, was selected to receive the annual Volwiller Research Achievement Award. The award is sponsored by the Abbott Fund and was established as the research prize in academic pharmacy. The award consists of a gold medal and a $12,500 cash prize. Dr. Georg will also be honored during the annual AACP meeting in Chicago in July.
The Minnesota Partnership for Biotechnology & Medical Genomics has awarded $775,577 to Peter Dosa, Associate Program Director in the Institute for Therapeutics Discovery & Development, for his project "Novel Therapeutic Agents for the Treatment of Glaucoma." Michael Fautsch of the Mayo Clinic will collaborate on the project.
Dr. Gunda Georg, Medicinal Chemistry Department Head and Director of the Institute for Therapeutics Discovery & Development, is quoted in a featured story on the College of Pharmacy home page. The February 12 posting discusses the history and development of a male contraceptive pill.
Dr. Georg's research was also covered by the Minnesota Daily and HealthTalk.
The PharmD students have chosen their 2012 Professors of the Semester for Fall 2012. This semester, Professor David Ferguson was honored by the Twin Cities class of 2016.
Professor David Ferguson gave his expert perspective in the January 2 Academic Health Center HealthTalk story "Adderall use in the NFL is 'cheating'."
Peter Dosa, Associate Program Director in the Institute for Therapeutics Discovery & Development, received a $50,000 grant from the Office of Discovery and Translation for the project "Development of Novel Therapeutics for Glaucoma." The grant is in collaboration with Michael Fautsch of the Mayo Clinic.
ITDD Director Gunda Georg is quoted in the November 26 SciBX online article "Solving triptolide," which discusses her research with Dr. Ashok Saluja and the development of minnelide.
Recent Comments